Table 2.
Haematological abnormal laboratory tests by all grade or grade ≥ 3 during the treatment period
| Laboratory abnormalities*, n (%) | Cabazitaxel (n = 112) | Abiraterone or enzalutamide (n = 105) | ||
|---|---|---|---|---|
| Any grade | Grade ≥ 3 | Any grade | Grade ≥ 3 | |
| Anaemia | 110/111 (99.1) | 7/111 (6.3) | 101/105 (96.2) | 4/105 (3.8) |
| Thrombocytopenia | 47/111 (42.3) | 3/111 (2.7) | 17/105 (16.2) | 2/105 (1.9) |
| Leukopenia | 84/111 (75.7) | 39/111 (35.1) | 28/105 (26.7) | 1/105 (1.0) |
| Neutropenia | 74/109 (67.9) | 51/109 (46.8) | 4/105 (3.8) | 2/105 (1.9) |
| Lymphopenia | 79/109 (72.5) | 29/109 (26.6) | 57/105 (54.3) | 15/105 (14.3) |
* Laboratories abnormalities were graded using National Cancer Institute Common Terminology Criteria version 4.03.